FLGT

20.10

0.95% 0.19

Dopo l'orario di chiusura: 20.10

Fulgent Genetics Inc (FLGT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$19.91

Aprire:

$19.94

Volume 24 ore:

229.54K

Relative Volume:

0.56

Capitalizzazione di mercato:

$663.21M

Reddito:

$290.71M

Utile/perdita netta:

$-163.43M

Rapporto P/E:

-3.6679

EPS:

-5.48

Flusso di cassa netto:

$11.70M

1 W Prestazione:

+2.71%

1M Prestazione:

-2.76%

6M Prestazione:

+9.12%

1 anno Prestazione:

+0.60%

Intervallo 1D:

$19.68

$20.19

Intervallo di 1 settimana:

$19.41

$20.37

Portata 52W:

$14.76

$25.11

Fulgent Genetics Inc Stock (FLGT) Company Profile

Nome

Fulgent Genetics Inc

Settore

Healthcare (1166)

Industria

Diagnostics & Research (54)

Telefono

626-350-0537

Indirizzo

4399 SANTA ANITA AVE, EL MONTE

Dipendente

1,313

Cinguettio

@FulgentGenetics

Prossima data di guadagno

2025-05-02

Ultimi documenti SEC

FLGT's Discussions on Twitter

Confronta FLGT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
FLGT Fulgent Genetics Inc	20.10	663.21M	290.71M	-163.43M	11.70M	-5.48
TMO Thermo Fisher Scientific Inc	427.76	156.49B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	202.50	145.01B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	542.71	42.30B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	120.66	34.24B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	164.65	27.64B	15.50B	1.33B	2.16B	7.34

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-07	Iniziato	UBS	Neutral
2022-12-08	Downgrade	Piper Sandler	Overweight → Neutral
2022-11-18	Iniziato	Raymond James	Outperform
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-02-04	Ripresa	Piper Sandler	Overweight
2021-08-05	Ripresa	Credit Suisse	Underperform
2021-01-08	Downgrade	Credit Suisse	Neutral → Underperform
2020-11-24	Downgrade	BTIG Research	Buy → Neutral
2020-08-20	Iniziato	Oppenheimer	Outperform
2020-05-29	Iniziato	BTIG Research	Buy
2019-11-05	Aggiornamento	Piper Jaffray	Neutral → Overweight
2018-03-01	Downgrade	Piper Jaffray	Overweight → Neutral
2017-11-07	Downgrade	Raymond James	Outperform → Mkt Perform

Mostra tutto

Fulgent Genetics Inc Borsa (FLGT) Ultime notizie

Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent - Bluefield Daily Telegraph

Jun 18, 2025

Jun 16, 2025

GAMMA Investing LLC Acquires 72,261 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jun 16, 2025

Jun 15, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent ... - Bluefield Daily Telegraph

Jun 15, 2025

Jun 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - PR Newswire

Jun 12, 2025

Jun 11, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,986 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jun 11, 2025

Jun 10, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jun 10, 2025

Bragar Eagel & Squire, P.C. Is Investigating Semler, - GlobeNewswire

Jun 10, 2025

Jun 09, 2025

Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages ... - Bluefield Daily Telegraph

Jun 09, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jun 09, 2025

Jun 08, 2025

Bank of America Corp DE Has $1.48 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Jun 08, 2025